PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23403306-2	2013	In this study, we introduced the human parental neural stem cells, HB1.F3, with the human interferon beta (IFN-beta) gene which is a typical cytokine gene that has an antitumor effect and the cytosine deaminase (CD) gene from Escherichia coli (E. coli) that could convert the non-toxic prodrug, 5-fluorocytosine (5-FC), to a toxic metabolite, 5-fluorouracil (5-FU).	Flucytosine	295-311	interferon beta 1	Homo sapiens	90-105	
21769425-5	2011	Treatment of a human non-small cell lung carcinoma cell line (A549, a lung carcinoma derived from human lung epithelial cells) with the pro-drug 5-fluorocytosine (5-FC) in the presence of HB1.F3.CD or HB1.F3.CD.IFN-beta cells resulted in the inhibition of lung cancer cell growth.	Flucytosine	145-161	interferon beta 1	Homo sapiens	211-219	
27188205-3	2017	MATERIALS AND METHODS: CD can convert a prodrug, 5-fluorocytosine (5-FC), to active 5-fluorouracil, which inhibits tumor growth through the inhibition of DNA synthesis,while IFN-beta also strongly inhibits tumor growth by inducing the apoptotic process.	Flucytosine	49-65	interferon beta 1	Homo sapiens	174-182	
23403306-2	2013	In this study, we introduced the human parental neural stem cells, HB1.F3, with the human interferon beta (IFN-beta) gene which is a typical cytokine gene that has an antitumor effect and the cytosine deaminase (CD) gene from Escherichia coli (E. coli) that could convert the non-toxic prodrug, 5-fluorocytosine (5-FC), to a toxic metabolite, 5-fluorouracil (5-FU).	Flucytosine	295-311	interferon beta 1	Homo sapiens	107-115	
22790964-6	2012	Treatment of Hep3B, human liver cancer cells, with the prodrug 5-fluorocytosine (5-FC) in the presence of HB1.F3.CD or HB1.F3.CD.IFN-beta cells resulted in the inhibition of Hep3B cell growth.	Flucytosine	63-79	interferon beta 1	Homo sapiens	129-137